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Background:Oxidative stress is known to play a role in critical illness due to an imbalance
in reactive oxygen species and reactive nitrogen species, and the body’s ability to detoxify
pro-oxidants using small molecule anti-oxidants and anti-oxidant enzymes.
Objective: To compare the concentrations of plasma redox metabolites and redox
potentials for the Cys/CySS and GSH/GSSG thiol/disulfide pairs in critically ill children
with healthy control children.
Methods: We performed a prospective clinical observational study of children ages
18 years and weight 6 kg, who were hospitalized between January 2010 and April
2012 in a 30-bedmultidisciplinarymedical-surgical pediatric intensive care unit (PICU).We
measured the plasma concentrations of Cys, CySS, GSH, and GSSG within the first 24 h
of PICU arrival, and we calculated the redox potential for the Cys/CySS (Eh Cys/CySS) and
GSH/GSSG (Eh GSH/GSSG) thiol/disulfide pairs in the plasma of 61 critically ill children
and 16 healthy control children.
Results: Critically ill children have less Cys (p=0.009), less CySS (p=0.011), less
Total Cys ([Cys]+2[CySS], p=0.01), more GSSG (p<0.001), and more oxidized Eh
GSH/GSSG (p<0.001) compared to healthy children.
Conclusion: Our results demonstrate that in the presence of pediatric critical illness,
the Total Cys/CySS thiol pool decreases while GSH is likely one component of the
cellular redox system that reduces CySS back to Cys, thus maintaining Eh Cys/CySS.
The Total Cys pool is more abundant than the Total GSH pool in the plasma of
children. Further investigation is needed to elucidate the differences in redox potentials
in subgroups of critically ill children, and to determine whether differences in redox
metabolite concentrations and redox potentials correlate with severity of critical illness
and clinical outcomes.
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Introduction
Oxidative stress (OS) causes irreversible damage to DNA, lipids,
and proteins (1–3), and is defined as a disruption of redox signal-
ing and control (4–6). The thiols cysteine (Cys) and glutathione
(GSH) are common sources of reducing equivalents for neutraliz-
ing oxidative stress. Critical Cys residues of many enzymes, recep-
tors, ion channels, transporters, and transcription factors also
sense oxidative stress and the oxidative state of these Cys residues
influence protein function (4, 5, 7–9).While other small molecule
anti-oxidants such as ascorbic acid, uric acid, tocopherols, and
carotenoids are important in maintaining redox state of cells,
the relative contribution of low molecular weight thiols to total
antioxidant capacity is not clear. In addition, the most abundant
thiols available for reducing equivalents in serum are albumin and
other protein thiols (10, 11).
Cysteine undergoes rapid autoxidation and is toxic to mam-
malian cells at concentrations exceeding the normal, low micro-
molar concentrations found in plasma (12). The toxicity of
Cys is controlled by incorporating cysteine into the tripeptide
GSH (13). While Cys and CySS constitute the predominant low-
molecular-weight thiol-disulfide pool in human plasma (14), GSH
is more likely to remain reduced in an oxidative environment
than Cys. GSH is also maintained in tissues at millimolar con-
centration with a relatively reduced redox state (15), indicat-
ing that the Cys/CySS and GSH/GSSG pool are not in equilib-
rium (14).
Clinical experience in adults has demonstrated that redox
balances of Cys and its disulfide cystine (CySS), and GSH
and its glutathione disulfide (GSSG) reflect antioxidant func-
tion (16). However, the redox balance of plasma Cys/CySS and
GSH/GSSG have not been well characterized in critically ill chil-
dren. This study compared the concentrations of Cys, CySS,
GSH, GSSG, and the redox potentials of the Cys/CySS (Eh
Cys/CySS) and GSH/GSSG (Eh GSH/GSSG) couples in plasma
of healthy and critically ill children. Once a difference between
redox potentials between healthy control and critically ill chil-
dren is established, correlation of these redox metabolites with
diagnoses, severity of illness scores, and clinical outcomes may
lead to the development of new biomarkers of pediatric critical
illness.
Patients, Materials, and Methods
We performed a prospective clinical observational study in the
pediatric intensive care unit (PICU) at Children’s Healthcare of
Atlanta at Egleston between January 2010 and April 2012. The
PICU is a 30-bed multidisciplinary medical-surgical ICU provid-
ing quaternary care for patients 0–21 years of age. This study was
approved by the Institutional Review Boards of Emory Univer-
sity and Children’s Healthcare of Atlanta. Informed consent was
obtained from each patient’s guardian.
Abbrevations: Cys, cysteine; CySS, cystine; CySSG, cysteine-glutathione disul-
fide (mixed disulfide); Eh, redox state calculated from Nernst equation; GSH,
glutathione; GSSG, glutathione disulfide.
Human Subjects
Pediatric intensive care unit (PICU) patients aged 0–18 years
weighing 6 kg were eligible for enrollment. Blood draws were
performed within 24 h of PICU admission. Healthy control chil-
dren were recruited by advertisement for comparison with PICU
patients, and controls were not compensated for their participa-
tion in this study. Exclusion criteria for controls included any
medication use and a physician diagnosis of chronic disease. Con-
trol children were evaluated during an outpatient-only research
visit that was rescheduled if upper respiratory infection or other
illnesses were present.
Demographic and clinical data such as age, gender, race, pri-
mary diagnosis, duration of mechanical ventilation, length of
pediatric intensive care unit stay (PICU LOS), length of hospital
stay (Hospital LOS), need for advanced technologies such as extra-
corporeal membranous oxygenation (ECMO), continuous veno-
venous hemofiltration (CVVH), and plasma exchange (PE) were
noted.
Determination of Severity of Illness
Septic shock was defined and classified according to the
American College of Critical Care Medicine (ACCM) defini-
tions of cardiovascular support (17). Severity of illness scores
were calculated using the Pediatric Risk of Mortality score III
(PRISM III) and pediatric logistic organ dysfunction (PELOD)
score (18–20).
Sample Collection, Processing, and Redox State
Calculations
After obtaining informed consent, plasma samples were imme-
diately placed on ice, and transported to the Emory+Children’s
Biomarker Core laboratory. Samples were placed in deriva-
tization solution to stop oxidation and analyses of plasma
were performed using high performance liquid chromatogra-
phy as previously described (21–23). Briefly, blood was col-
lected from controls by peripheral venipuncture or from PICU
patients by accessing a central venous line, and 0.25ml was
immediately transferred to a microcentrifuge tube containing
0.25ml of a preservation solution containing 100mM serine-
borate (pH 8.5) containing (per ml) 0.5mg sodium heparin,
1mg bathophenanthroline disulfonate sodium salt (BPDS), and
2mg iodoacetic acid (21, 22). This procedure has been shown to
minimize autoxidation and hemolysis (22). Following centrifu-
gation to remove blood cells, aliquots (125µl) were transferred
to tubes containing 125µl of 10% (w/v) perchloric acid con-
taining 0.2M boric acid and 10µM γ-- glutamyl--glutamate
as an internal standard. Samples were stored at  80°C prior
to further processing to form N-dansyl derivatives and anal-
ysis by HPLC with fluorescence detection. Metabolites were
identified by co-elution with standards, and quantification was
obtained by integration relative to the internal standard (22).
Total Cys and Total GSH were calculated using the equations:
[Cys]+ 2[CySS] and [GSH]+ 2[GSSG], respectively. The redox
states (Eh) of the thiol/disulfide pools were calculated with the
Nernst equation using standard potentials for the GSH/GSSG
( 264mV) and Cys/CySS ( 250mV) pairs at pH 7.4, as previ-
ously described (16, 24).
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Statistical Methods
All statistical analyses were performed using SAS 9.3 (Cary, NC,
USA) and statistical significance was assessed at the 0.05 sig-
nificance level unless otherwise noted. Since specific differences
in metabolite and redox values are difficult to predict, statistical
power was evaluated by utilization of an effect size. Samples of 61
cases and 16 controls were obtained giving 80% power to detect
an effect size of 0.8 using a two-sampleWilcoxon-test. Prior to the
analysis, the assumption of normality for themetabolite and redox
values was assessed using the Shapiro-Wilk test for normality and
by visual inspection of the histograms. As has been previously
reported (16), evaluation of metabolite data demonstrated that
none of themetabolites, with the exception of the redox potentials
(Eh), were normally distributed, and thus, values were log trans-
formed and adjusted for differences in age, gender, and race using
generalized linear models. Back-transformed least-squares means
and 95% confidence intervals are reported. Discrete variables are
shown by frequency counts and percentages.
Results
Subjects and Clinical Characteristics
Demographic data are listed in Table 1. Primary diagnoses
in the category labeled “Other” included: severe head trauma,
post-operative from spinal fusion surgery, cerebral hypertension,
tuberculosis, status epilepticus, brain abscess, post-bronchial for-
eign body, pertussis, traumatic brain injury, acute chest syndrome,
parapneumonic effusion, neutropenic fever, and demyelinating
central nervous system disease.
Redox Status of PICU Subjects Compared with
Healthy Children
Redox data from the PICU subjects and healthy control chil-
dren are shown in Figure 1. After adjusting for age, gender, and
race, children admitted to the PICU had 2.5 times less Cys (2.29
vs. 0.91µM; p= 0.009), 2.8 times less CySS (2.98 vs. 1.05µM;
p= 0.011), and 2.5 times less Total Cys (8.52 vs. 3.41µM; p= 0.01)
(Figure 1A). Children admitted to the PICU had no difference in
GSH concentrations (0.29 vs. 0.22µM; p= 0.573) or Total GSH
(0.37 vs. 0.69µM; p= 0.106), but PICU patients had 13 times
more GSSG (0.01 vs. 0.13µM; p< 0.001) than healthy control
children (Figure 1B). Finally, children admitted to the PICU
showed no difference in Eh Cys/CySS ( 77 vs. 67mV; p= 0.095)
compared to healthy children; however, critically ill children
had a ~40mV more oxidized Eh GSH/GSSG ( 113 vs.  71mV;
p< 0.001, Figure 1C) compared to healthy control children.
Redox Status as a Function of Age, Gender,
Primary Diagnosis, Severity of Illness Scores,
Use of Advanced Technologies, and Clinical
Outcomes in PICU Patients
Children in the PICU with organ dysfunction requiring advanced
technologies (n= 10) such as ECMO, CVVH, and PE have less
Cys [Median (IQR) 0.5µM (0.3–0.57) vs. 1.02µM (0.25–2.6);
p= 0.027], less CySS [0.24µM (0.1–0.54) vs. 0.79µM (0.44–3.64);
p= 0.027], and less Total Cys [1.02µM (0.64–1.60) vs. 2.85µM
(1.26–11.15); p= 0.019] when compared with other children
TABLE 1 | Demographics, primary diagnosis, and severity of illness mea-
sures.
Characteristic PICU
(n= 61)
Controls
(n= 16)
p
Age (year), median (IQR) 11:5 (6:1–16:4) 9:7 (8:4–11:5) 0.697
Gender, n (%)
Male 36 (59) 3 (19) 0.005
Female 25 (41) 13 (81)
Race, n (%)
African American 38 (62:3) 10 (62:4)
Caucasian 18 (29:5) 3 (18:8)
Multiple races 3 (4:9) 0 (0) 0.107
Asian 1 (1:6) 3 (18:8)
Pacific Islander 1 (1:6) 0 (0)
Ethnicity, n (%)
Hispanic 4 (6:6) 0 (0)
Primary diagnosis, n (%)
Septic Shock 24 (39:3)
Asthma 11 (18:0)
Shock 8 (13:1) NA
Sepsis 4 (6:6)
Other 14 (23:0)
Oncologya, n (%) 9 (12:9)
Solid tumor 5 (55:6) NA
Hematological 4 (44:4)
Severity of illness measures, mean (SD)
PRISM III score 11:1 (5:3) NA
PELOD score 15:5 (13:7)
Length of stay (days), median (IQR)
PICU 6:0 (3:0–9:0) NA
Hospital 9:0 (5:0–19:0)
Mechanically ventilated, n (%) 37 (60:7) NA
Time on ventilator (days), median (IQR) 6:0 (3:0–8:0) NA
Advanced technologiesb, n (%) 10 (16:4)
ECMO 5 (50)
CVVH 8 (80) NA
PE 3 (30)
28 days mortality, n (%) 3 (4:9) NA
IQR, 25th–75th interquartile range.
NA, not applicable.
aEight oncology patients had a primary diagnosis of septic shock and one had an “Other”
diagnosis of neutropenic fever.
bECMO, extracorporeal membrane oxygenation; CVVH, continuous venovenous
hemodialysis; PE, plasma exchange. The total percentage of patients receiving advanced
technologies is >100%, because some patients received more than one type of advanced
technology.
admitted to the PICU (n= 51). There was no difference in Eh
Cys/CySS [Mean (SD)  64mV (13) vs.  66mV (7); p= 0.911]
or any of the GSH redox parameters (p> 0.8) measured when
comparing the patients receiving advanced technologies with the
remaining PICU patients. We compared redox metabolite values,
Eh Cys/CySS, and Eh GSH/GSSG across age and gender and found
no significant differences for the PICU patients. There were no
strong correlations (ρ 0.4) significant between primary diagno-
sis, severity of illness scores, such as PELOD and PRISM III score,
or clinical outcomes such as, PICU LOS, Hospital LOS, or days of
mechanical ventilation with redox metabolites, Eh Cys/CySS, or
Eh GSH/GSSG.
Discussion
This study compared the plasma redox metabolite concentrations
and redox potentials for the Cys/CySS and GSH/GSSG pairs
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FIGURE 1 | Bar graphs comparing concentrations of (A) Cys (μM), CySS
(μM), and Total Cys (μM); (B) GSH (μM), GSSG (μM), and Total GSH (μM);
(C) Eh Cys/CySS (mV) and Eh GSH/GSSG (mV) of healthy children controls
with PICU patients. Individual bars indicate least-squares mean values and the
whiskers represent 95% confidence intervals. Metabolite concentration data
were log-transformed, and the back-transformed least-squares means are
presented. The Eh are normally distributed, and a less negative number reflects a
more oxidized redox value. All metabolite and Eh values were adjusted for age,
gender, and race. p-Values are listed above the pairs being compared.
(D) Represents a model summarizing the redox data in (A–C), adapted from
Jones et al. (16). The Total Cys concentration is higher than that of Total GSH.
Because Cys is more abundant and more readily oxidized than GSH (as
indicated by a less negative redox potential), Cys is preferentially oxidized to
CySS in plasma. GSH in the plasma serves as a reducing pool to convert CySS
back to Cys, thus maintaining the Eh Cys/CySS in critically ill children nearly
equal to that of healthy children. The redox balance of Cys is preserved by the
supply of GSH from tissues. Red ovals represent a significant decrease in
concentration of a metabolite. Blue ovals represent a significant increase in
concentration of a metabolite or a more oxidized redox potential (Eh). Ovals are
not representative of the magnitude of change and are not drawn to scale.
between critically ill and healthy children. We found that in criti-
cally ill children, the total Cys/CySS thiol pool was ~2.5 times less
than that in healthy children. Despite the reduction in Total Cys in
critically ill children, the Eh Cys/CySS in critically ill children was
maintained at healthy control levels. However, the Eh GSH/GSSG
was ~40mV more oxidized in critically ill vs. healthy children.
These findings suggest that while Cys/CySS is the most abundant
low-molecular-weight thiol-disulfide pool in plasma (23 times
more abundant in plasma of healthy children than the GSH/GSSG
pool), GSH is a better reducing agent than Cys as denoted by a
more negative redox potential. Therefore, GSH reduces CySS back
to Cys in critically ill children, thus maintaining Eh Cys/CySS as
summarized in Figure 1D, based on a model derived by Jones
et al. (16).
This is not the first study to measure cysteine and glutathione
concentrations in children. Lyons and colleagues measured Cys
metabolism and glutathione synthesis in 10 septic pediatric
patients and compared with 10 post-operative controls (25).
Results from the Lyons study showed that there was no difference
in Cys or CySS levels when methionine intake was controlled;
however, a 60% decrease in GSH synthesis rates was noted in
septic patients vs. controls (25). Németh and Boda measured a
xanthine oxidase activity index and a GSSG/GSH ratio in infants
and children with septic shock and showed that these indices were
significantly correlated with each other, with severity of illness
scores (PRISM), and were increased in patients in a proinflam-
matory state (26). Our results extend this work by adding the
Eh Cys/CySS and Eh GSH/GSSH to the literature of pediatric
acute critical illness. Redox potential, calculated using the Nernst
equation, accounts for the stoichiometry of two electron transfers
as two GSH are involved in the oxidation to GSSG (6). As an
example, the ratio of GSH/GSSG is also used to quantify reducing
force for this thiol/disulfide pair; however, a GSH/GSSG ratio of
100 has very different reducing power for a GSH of 10mM and a
GSSG of 100µMwith an Eh GSH/GSSG of 264mV vs. a GSH of
100µM and a GSSG of 1µMwith an Eh GSH/GSSG of 204mV
(27, 28). While many assays exist for measuring individual pro-
oxidant and anti-oxidant levels, the reason for quantifying the Eh
Cys/CySS andEhGSH/GSSG in serum is that it provides an overall
measure of the pro-oxidant/anti-oxidant balance (6, 28).
Fitzpatrick and colleagues have measured the Eh Cys/CySS and
Eh GSH/GSSH of mild-to-moderate and severe asthmatics (23).
In comparison, PICU patients from the current study (mean Eh
Cys/CySS  65mV) have a significantly more oxidized Cys/CySS
redox potential than mild-to-moderate asthmatics (mean Eh
Cys/CySS 95mV) and are similarly oxidized to severe asthmatics
in the Fitzpatrick study (mean Eh Cys/CySS 55mV). The subset
of PICU patients admitted with a primary diagnosis of asthma
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(n= 11) tended to be the most oxidized subset of patients in the
PICU with a mean Eh Cys/CySS  51mV. For the GSH/GSSG
redox state, severe asthmatics in the Fitzpatrick study (23) have a
mean Eh GSH/GSSH of  90mV similar to asthmatics admitted
to the PICU in this study (Eh GSH/GSSG  93mV). Due to
the small numbers of asthmatics enrolled in our study, the Eh
Cys/CySS and Eh GSH/GSSG results of patients admitted to the
PICU with a primary diagnosis of asthma are not significantly
different when compared with PICU patients with other primary
diagnoses.
The current prospective study has several limitations. It is a
small single-center study comparing critically ill children with
diverse diagnoses. Because of the small number of patients
with a variety of diagnoses, the study was not adequately pow-
ered to detect correlations between redox markers, clinical diag-
noses, severity of illness scores, or outcomes such as length
of PICU stay or duration of mechanical ventilation. We mea-
sured plasma redox markers, but measurements of local tissue
redox metabolites, for example redox metabolites in the lung of
asthmatics or in those with acute lung injury, may be a more
relevant marker of OS in the microenvironment of the lung.
We did not compare other biomarkers of oxidative stress or
anti-oxidant potential with Eh Cys/CySS and Eh GSH/GSSG,
such as levels of ascorbic acid, 4-hydroxynonenal, malondialde-
hyde, F2-isoprostanes, or enzymatic activity of common redox
enzymes such as superoxide dismutase, glutathione peroxire-
doxin, or thioredoxin. This lack of comparison is not unique
to our study, and there are several studies comparing plasma
biomarkers of oxidative stress in adults have not resulted in cor-
relations among oxidative stress markers or clinical outcomes
(29–33). In addition, a recently published study of lipopolysac-
charide (LPS) induced sepsis in a porcine model did not show
any correlation of many redox markers with each other or with
clinical severity of illness (34). Despite these limitations, our data
are in agreement with some of the findings of prior studies in
septic children (25, 26), and confirm that significant differences
exist in the Eh GSH/GSSG, rather than Eh Cys/CySS, of chil-
dren admitted to a PICU when compared to healthy control
children.
In summary, a decrease in the abundance of Total Cys, an
increase in GSSG, and a more oxidized Eh GSH/GSSG may
serve as potential markers of OS events in the plasma of crit-
ically ill children. Understanding changes that occur in redox
metabolites, redox potentials, and redox signaling pathways in
childhood diseases may lead to novel prognostic markers and
therapeutic targets in pediatric critical illness. Future studies
will work toward assessing the role of protein thiols, other
markers of oxidative stress, and signal transduction pathways
to elucidate the mechanism of oxidative stress in critically ill
children. In addition to studying the biological mechanisms
of how changes in Eh Cys/CySS and Eh GSH/GSSG correlate
with other markers of OS and influence redox sensitive redox
signaling pathways, we plan on evaluating whether the bal-
ance of Cys/CySS and GSH/GSSG can differentiate subpopula-
tions of critically ill children with differing severity of critical
illness.
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